The 2nd International

Human Gene Therapy
Conference

December 04-06, 2024 | Paris, France

Key Dates of Gene Forum

March 30, 2024

Abstract Submission Commencement

April 10, 2024

Registration Commencement

June 30, 2024

Abstract Submission Deadline

July 15, 2024

Early-bird Registration Deadline

// ABOUT CONFERENCE

Welcome to the 2nd International Human Gene Therapy Conference Paris 2024 Harmonizing Health Worldwide

We are thrilled and overwhelmed to announce the Gene Forum 2024 the sequel to the highly successful
Gene Forum 2022 conference. This international summit, set against the backdrop of Paris, France, marks our commitment to pushing the boundaries of gene therapy. A cordial invitation is extended to you as we embark on this transformative journey. Gene Forum 2024 is a meticulously curated event designed to illuminate the panorama of gene therapy, not just in Europe but on a global scale. Our objective is to cultivate collaboration among pivotal figures in gene therapy—bringing together , Industry spearheads, and Collaborators. The conference aspires to unite influential figures in the gene therapy sector.
It provides an invaluable platform for exchanging innovative fresh findings and trends in gene therapy—a field poised to revolutionize healthcare by addressing genetic disorders and advancing personalized medicine. Gene Forum is uniquely tailored to deliver actionable insights, expert guidance, peer networking, and assessments from solution providers. The experience promises to be unforgettable and transformative, empowering you and your organization to achieve heightened performance in addressing critical priorities, offering a chance to showcase innovations and connect with industry leaders. We believe in the power of collaboration, and the success of Gene Forum 2022 showcased the importance of active participation. Regardless of where you stand in the gene therapy value chain, your voice matters, and we invite you to join us at Gene Forum 2024. The significance of gene therapy in revolutionizing medical care and addressing genetic challenges cannot be overstated. Gene therapy stands at the forefront of medical innovation, and its impact resonates globally. Despite the challenges, the imperative for breakthroughs in treating genetic conditions necessitates collaboration, shared knowledge, and a collective effort. Gene Forum 2024 provides a platform to explore the latest advancements, engage in discussions, and share ideas. The summit will host thought-provoking sessions to create an environment conducive to meaningful interactions and collaborations. Secure your place early at Gene Forum 2024, where we anticipate a surge in interest. Register now to be part of this premier interdisciplinary platform for Industrialists, Researchers, Practitioners, and Educators shaping the future of gene therapy.

// SCIENTIFIC SESSION

Key Topics

  • Gene Delivery Technologies
  • Clinical Trials and Therapeutic
  • Efficient Human Genome Editing
  • Market Trends and Opportunities
  • Regulatory Landscape
  • Investment and Funding Opportunities
  • Manufacturing and Supply Chain Strategies
  • Clinical Development and Trial Design
  • Technology Innovations
  • Collaborations and Partnerships
  • Commercialization and Market Access
  • Ethical and Societal Considerations
  • Post-Market Surveillance and Real-World Evidence
  • Intellectual Property and Licensing

Gene Forum Market in Europe

The gene therapy market in Europe is experiencing notable growth, driven by increased research, development, and commercialization activities. Gene therapy, involving the modification of genetic material to treat or prevent diseases, has gained traction in Europe due to technological advancements, a supportive regulatory environment, and rising investments. Europe's gene therapy market benefits from a robust regulatory framework that encourages innovation and expedites the approval process. Regulatory bodies, including the European Medicines Agency (EMA), have adapted guidelines to address the unique challenges of gene therapies, fostering an environment conducive to clinical trials and market introduction. Investment and funding in the gene therapy sector have seen a significant uptick, with both public and private sectors recognizing the therapeutic potential of these innovative approaches. Collaborations between industry players, academic institutions, and research organizations have intensified, creating a synergistic ecosystem that accelerates the development of novel gene therapies. Technological advancements, especially in gene editing technologies like CRISPR-Cas9, have played a crucial role in shaping the gene therapy landscape in Europe. Researchers and companies are exploring innovative vector designs, delivery systems, and manufacturing processes to enhance the precision, efficiency, and scalability of gene therapies. The market is witnessing increased activity across various therapeutic areas, including rare genetic disorders, oncology, and neurodegenerative diseases. As gene therapies progress from research and development to commercialization, considerations such as market access, pricing, and reimbursement strategies have become critical for stakeholders in Europe’s healthcare landscape. The Europe gene therapy market is segmented into four notable segments based on vector type, method, application, and end user. Germany is dominating due to the presence of key market players in the largest consumer market with a high GDP. The U.S. is expected to grow due to the rise in technological advancement in the gene therapy products market. The European gene therapy market is projected to grow at a CAGR of 17.6% during the forecast period by 2030 and the future market value is expected to reach USD 7,422.28 million by 2030.

Why Attend the Gene Therapy Conference

  • Stay Informed on the Latest Research works and happenings on Gene Therapy
  • Meet Experts and Key Opinion Leaders
  • Exposure to Diverse Perspectives of Gene Therapy
  • Access to Industry Exhibits and Technologies
  • QARA Challenges and Solutions
  • Ethical Considerations and Challenges
  • Investments, Partnerships, and Fundings on a Global Scale
  • Global Collaboration and Policy Engagement
  • Networking Opportunities
  • Professional Development
  • Career and Business Opportunities

Who will Attend Gene Forum Conference?

Department

  • Manufacturing
  • Product Development
  • Quality
  • Value & Market Access
  • Therapy Administration
  • Research & Development
  • Regulatory Affairs
  • Vector Systems
  • Engineering
  • Laboratory
  • Science
  • Information Technology
  • Validation
  • Training
  • Clinical
  • Patient Advocacy

Job Function

  • Scientist
  • Executive and Mid-Level Management
  • Project Management
  • Technical Services
  • Supply Chain
  • Manufacturing
  • Application
  • Risk Management
  • Patient Monitoring
  • Customer Engagement
  • Marketing and Sales
  • Clinical Strategy Pharmacist
  • Product Communications
  • Clinical Research
  • Post Doc, PhD Student
// Programs

Program Schedule

Exhibition Setup Day
  • Exhibitors Booth Setup
    14:00-18:00
  • Exhibitors and Sponsors Dinner
    18:00-20:00
Day - 1 [December 04, 2024]
  • 09:00-09:30
    Inaugural ceremony
  • 09:30-10:30
    Keynote Presentation
  • 10:30-11:00
    Break
  • 11:00- 12:00 Gene Delivery Technologies
  • 12:00-13:00
    - Clinical Trials and Therapeutic Applications
    - Exploring Diverse Applications
  • 13:00-14:00
    Lunch Break
  • 14:00-15:00 - Panel Discussion
  • 15:00-16:00
    - Market Trends, Investment and Funding Opportunities
  • 16:00-16:30
    Break
  • 16:30-17:30 - Manufacturing and Supply Chain Strategies


Media Partners

geneonline
genenet
pm360


For regular updates bookmark gene therapy conferences website